Robert Repetto

Title: The Innovations of Robert Repetto

Introduction

Robert Repetto is a notable inventor based in Garrison, NY (US). He has made significant contributions to the field of virology, particularly in the study of respiratory syncytial virus (RSV). His work has implications for the development of immunogenic compositions that can protect against RSV-related diseases.

Latest Patents

Robert Repetto holds a patent for a process aimed at increasing RSV surface glycoprotein yields using a mutant strain of RSV. This innovative process allows for the production of isolated and purified RSV fusion (F) and attachment (G) glycoproteins in eukaryotic cell cultures. The method utilizes a cold-passaged, temperature-sensitive mutant subgroup A2 strain cpts-248/404, resulting in at least a 5-fold increase in F and G protein yields compared to the parent A2 strain. The immunogenic compositions derived from this process can be formulated for in vivo administration to confer protection against RSV-related diseases.

Career Highlights

Robert Repetto has been associated with Wyeth Holdings Corporation, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of RSV and developing potential therapeutic solutions.

Collaborations

Throughout his career, Robert has collaborated with notable colleagues, including Mark William Cutler and Mirelli Fino. These partnerships have enhanced the research and development efforts in the field of virology.

Conclusion

Robert Repetto's innovative work in increasing RSV glycoprotein yields showcases his dedication to advancing medical science. His contributions have the potential to significantly impact the treatment and prevention of RSV-related diseases.